Monsenso has moved on from scrum and are now using the shape up method. This has meant changes …. In a good way.

Over the past decade, public spending on health in Denmark has been above the EU average. But how does Denmark decide which new treatment approaches to spend money on, and does the societal impact of healthcare measures play an equally important role as their economic impact?

April is Stress Awareness Month, which aims to shine light on stress and its consequences on our well-being, removing stigma and shame around mental health.

March 30th is World Bipolar Day. The awareness day aims to inform about the mental illness and the struggles it can cause for individuals suffering from it, improving sensitivity and eliminating social stigma.

The input from both end-users and clinicians is a crucial part of the design phase in the PhaseV project, where Monsenso and partners will develop a range of new digital health solutions for future clinical trials.

How do patients who have received psychiatric treatment for depression experience the sector transition into the primary sector? And what are their needs for treatment and care from different healthcare sectors? The DEPRIC research project is now trying to find answers and thereby develop a new treatment model for depression across healthcare sectors in Denmark.

Together with a European consortium of partners, Monsenso has received a grant letter on a new community-based intervention project that includes development and trial of a digital health intervention delivered on Monsenso’s platform to prevent mental illness among vulnerable groups.

Monsenso and a consortium of partners have received a grant letter from a funding entity to develop and trial a new, AI-enabled personalised therapy concept for people with mental disorders.

In order to fight non-communicable diseases and support the people suffering from them, the European Commission has launched the Healthier together – EU Non-Communicable Diseases Initiative (EU NCD Initiative), aimed at covering the period from 2022 to 2027.

Monsenso’s new product enhancements entail an improved and even more intuitive user interface of the solution’s patient app and clinical web portal.